KLK3 and cancer: Genes encoding a number of MS proteins that are currently used as cancer markers or targets of therapeutic antibodies were identified by our approach, including KLK3 (PSA), AFP, EGFR, ERBB2, CEACAM5 (CEA), and VEGF. Their expression patterns were generally consistent with previous studies.